HLB제약

047920KOSDAQ자연과학 및 공학 연구개발업

63.7 / 100

Reference Date: 2026-04-13

Financial Score20.0 / 40

News Sentiment16.7 / 25

Momentum17.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Surged 16.1% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

HLB Pharmaceuticals, established in 1998, focuses on specialty pharmaceutical manufacturing, CMO services, and health functional food sales. In 2025, it expanded into pharmaceutical distribution by acquiring 100% of Shinwha Advance, achieving a 2025 revenue of 2.055 trillion KRW with a 34% CAGR over five years. The company leverages its DDS technology for long-acting injectables and diversified growth through its joint health functional food brand 'Kwancheol'.

Number of Employees

185people

Average Salary

54.0M KRW

Score Calculation Basis

Detailed Financial Score

PER

123.55Industry Average 120.073.0Point

Higher than industry avg (caution)

PBR

4.57Industry Average 3.822.5Point

Higher than industry avg (caution)

ROE

3.79Industry Average -32.113.5Point

Well below industry avg

Debt Ratio

4.72Industry Average 7.525.0Point

Lower than industry avg (good)

Trend 2023~20256.0 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲25.4% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲39.9% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -5.5% (improving, 3yr)

Detailed News Sentiment

3 totalPositive 1Neutral 1Negative 0Average Sentiment Score 75

Positive
NS홈쇼핑, ‘청패 맥문동 진액’ 출시
NS홈쇼핑이 환절기 건강 관리 수요에 맞춰 HLB제약의 건강기능식품 '청패 맥문동 진액'을 출시하며 전통 배합 원리와 특화된 추출 공정을 적용했다.
Neutral
[틈새유통] 유통가 '론칭 열전'…먹거리부터 패션까지 신상품 경쟁
유통업계가 차별화 상품 론칭을 통해 고객 확보에 나서고 있으며, 홈쇼핑은 프리미엄 패션과 건강식품 론칭 방송을 통해 경쟁하고 있다.

Detailed Momentum

52-week position5.0Point

52w mid range (55%)

Current 17,420Won52-week high 20,90052-week low 13,040

1-month return6.0Point

1m +16.06% (strong rise)

Volume trend6.0Point

Volume surge

Detailed Disclosure

4 totalPositive 0Neutral 4Negative 0

Neutral[기재정정]사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-27
Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-26
Neutral사업보고서 (2025.12)2026-03-19
Neutral감사보고서제출2026-03-18